Literature DB >> 7252515

IgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients.

B Ziola, M Reunanen, A Salmi.   

Abstract

Paired serum and cerebrospinal fluid (CSF) specimens from 30 multiple sclerosis (MS) patients and 30 matched neurological control (NC) patients were quantitatively tested for IgM-class rheumatoid factor (RF). Significantly elevated RF levels were found in serum from 6 MS patients and 12 NC patients. Seven of the latter 12 patients had a diagnosis of recurrent head pain. RF was detected in CSF from 2 MS patients and 2 NC patients. In 3 of the 4 cases, this could be explained by blood-brain barrier damage or normal diffusion of RF into CSF. Intrathecal RF synthesis was found in the remaining MS patient. These results suggest that RF production may be related to underlying pathological mechanisms in at least some MS and NC patients. They also confirm that RF must be carefully accounted for in etiological studies designed to demonstrate pathogen-specific IgM antibodies in, for example, MS patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252515     DOI: 10.1016/0022-510x(81)90063-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Immune complexes in CSF and serum in various neurological diseases.

Authors:  M Cavalli; E Merelli; P Sola; G Pirrò; P Faglioni
Journal:  Ital J Neurol Sci       Date:  1986-04

2.  Intrathecal synthesis of virus antibodies in multiple sclerosis patients.

Authors:  T Arnadottir; M Reunanen; A Salmi
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

3.  Coincidental fluctuations of humoral immunity and clinical progression in a patient with subacute sclerosing panencephalitis.

Authors:  B Friis; B Bloch; V Faber; A Salmi; B Ziola
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

4.  Intrathecal antibody synthesis to virus antigens in multiple sclerosis.

Authors:  A Salmi; M Reunanen; J Ilonen; M Panelius
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

Review 5.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.